Carisoprodol Tablet
Product Images NDC 65862-693

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 65862-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg (100 Tablet Bottle))

Label for Carisoprodol Tablets, USP 250 mg, a drug for further processing. The label indicates 100 tablets per container and is distributed by Aurobindo Pharma USA, Inc., made in India. It includes storage instructions and dosage information references.*

FDA Label Image

Package Label-principal Display Panel (350 mg (100 Tablet Bottle))

Label for Carisoprodol Tablets, USP 350 mg, a drug for further processing. The label indicates 100 tablets per container, distributed by Aurobindo Pharma USA, Inc. Made in India. The label includes dosage information, storage instructions, and a barcode.*

FDA Label Image

Str1 (Carisoprodol Str)

Chemical structure of carisoprodol, depicting its molecular arrangement with labeled functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.